Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research findings about schizophrenia gene offer hope for better drugs

21.04.2006
A research team from Uppsala University and AstraZeneca has found that the schizophrenia gene QKI affects the production of myelin, the material that insulates nerve fibers. It is hoped that these findings will lead to enhanced treatment of schizophrenia. The findings are being published in the Net edition of PNAS (Proceedings of the National Academy of Sciences) in mid-April.

The research group has previously shown that the QKI gene is a possible contributing cause of the disease schizophrenia. Now the scientists have found that QKI normally regulates the myelin genes, that is, the genes that govern the production of myelin, the insulation material for nerve fibers.

Moreover, the research team can show that the genetic expression of QKI is altered in schizophrenic patients and that the change correlates directly with the change in the myelin gene expression.

“In schizophrenics, fewer myelin proteins and less myelin are produced, we believe. Since myelin functions as an insulating substance around nerve fibers, impulse transmission is hampered in schizophrenics,” explains Elena Jazin.

The team of scientists has also seen that a variant of QKI called 7kb is the variant that changes most in schizophrenic patients. This 7kb also has a major effect on the expression of myelin genes in these patients.

“Just how the reduction of myelin affects the symptoms in schizophrenic patients is something we must investigate further,” says Elena Jazin.

It is hoped that the new findings will lead to improved treatment of schizophrenia in the future.

“We hope that existing drugs can be altered so that more patients will be helped and the side effects reduced. Perhaps the findings will also lead to new medicines. But this will require research and will take a long time,” says Elena Jazin.

Schizophrenia is one of the most common psychiatric public health disorders, affecting an average of one percent of the population of the world. Today’s methods of treatment can partially alleviate the symptoms, but many patients are not helped at all by them. Normally patients become ill between the ages of 15 and 30 and remain so for the rest of their lives.

The Uppsala University scientists in the research group are, besides Elena Jazin, Karolina Åberg and Peter Saetre. Niclas Jareborg has participated from AstraZeneca.

Linda Nohrstedt | alfa
Further information:
http://www.pnas.org/
http://www.uu.se

More articles from Life Sciences:

nachricht Complementing conventional antibiotics
24.05.2018 | Goethe-Universität Frankfurt am Main

nachricht Building a brain, cell by cell: Researchers make a mini neuron network (of two)
23.05.2018 | Institute of Industrial Science, The University of Tokyo

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Could a particle accelerator using laser-driven implosion become a reality?

24.05.2018 | Physics and Astronomy

Hot cars can hit deadly temperatures in as little as one hour

24.05.2018 | Health and Medicine

Complementing conventional antibiotics

24.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>